- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pharma Pulse 11/20/24: Impact of ALZ on Heath Equity, Seasonal Flu Returns to Pre-Pandemic Levels, & More
The latest news for pharma industry insiders.
The Impact of Alzheimer’s Disease Treatments on Health Equity
Could health system changes that improve patient access to medication have a positive effect on societal welfare?
Spread of Seasonal Flu Returns to Pre-Pandemic Levels After End of COVID-19 Global Emergency
Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.
Trump Wants RFK Jr. to ‘Go Wild’ on Healthcare. Investors Need Not Panic
The vaccine skeptic may find it hard to enact sweeping changes to American healthcare.
National Ataxia Foundation Hosts Congressional Briefing with Bill Nye, The Science Guy
The National Ataxia Foundation (NAF) partnered with members of Congress to host an informational meeting for legislators, their staff and other interested parties to provide education regarding Spinocerebellar Ataxia (SCA), a group of rare and debilitating hereditary neurodegenerative diseases that frequently impact multiple family members at the same time, with no cure or FDA-approved treatment.
EVERSANA on LinkedIn
Expanding Horizons! Last month, we announced the opening of our new office in Berlin, marking a significant step in our European expansion. As Mike Ryan explains in this interview with Pharmaceutical Executive, this move strengthens our ability to navigate diverse regulatory landscapes and deliver tailored solutions to meet local healthcare needs.
#GlobalExpansion #Pharmaceuticals #Berlin
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
